scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1750-3639.2012.00631.X |
P8608 | Fatcat ID | release_lthxisxmkncg5neqrpjcik5rde |
P698 | PubMed publication ID | 22966790 |
P50 | author | Arie Perry | Q37837647 |
Vijay Ramaswamy | Q43153342 | ||
Charles G Eberhart | Q87148391 | ||
Paul A Northcott | Q91826566 | ||
P2093 | author name string | Michael D Taylor | |
James M Olson | |||
Sameer Agnihotri | |||
Sidney E Croul | |||
Adrian M Dubuc | |||
Donya Aref | |||
Connor J Moffatt | |||
P2860 | cites work | Molecular subgroups of medulloblastoma: the current consensus | Q24615271 |
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Subtypes of medulloblastoma have distinct developmental origins | Q28300616 | ||
Cerebellum development and medulloblastoma | Q28304753 | ||
Development and cancer of the cerebellum | Q28305235 | ||
Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation | Q28505942 | ||
DNA array analysis of the developing rat cerebellum: transforming growth factor-beta2 inhibits constitutively activated NF-kappaB in granule neurons | Q28575059 | ||
The polycomb group protein EZH2 is involved in progression of prostate cancer | Q29614514 | ||
TM4 microarray software suite | Q29618829 | ||
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
Central nervous system neuronal migration | Q33593457 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features | Q34866372 | ||
Smad2 protein disruption in the central nervous system leads to aberrant cerebellar development and early postnatal ataxia in mice | Q34998146 | ||
Clonal selection drives genetic divergence of metastatic medulloblastoma | Q35784926 | ||
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples | Q35837393 | ||
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway | Q35907425 | ||
Morphing into cancer: the role of developmental signaling pathways in brain tumor formation | Q36205991 | ||
c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer | Q36294128 | ||
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 | ||
Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development | Q36509989 | ||
Transforming growth factor-beta in cancer and metastasis | Q36585129 | ||
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons | Q36735270 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
The origins of medulloblastoma subtypes | Q37014819 | ||
Noncanonical TGF-β signaling during mammary tumorigenesis | Q37044600 | ||
Role of TGF-β and the tumor microenvironment during mammary tumorigenesis | Q37044604 | ||
The TGF-beta paradox in human cancer: an update | Q37261631 | ||
Molecular diagnostics of CNS embryonal tumors | Q37794829 | ||
Medulloblastomas: update on a heterogeneous disease | Q37926454 | ||
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. | Q39469388 | ||
MicroRNA-21 suppression impedes medulloblastoma cell migration | Q39503647 | ||
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma | Q39593013 | ||
FOXG1 dysregulation is a frequent event in medulloblastoma | Q40128459 | ||
Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence | Q41980817 | ||
Enhanced neurogenesis from neural progenitor cells with G1/S-phase cell cycle arrest is mediated by transforming growth factor beta1. | Q46376497 | ||
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression | Q46507354 | ||
Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc. | Q46939297 | ||
Smad2/3 activities are required for induction and patterning of the neuroectoderm in zebrafish | Q47074019 | ||
TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis | Q48125390 | ||
Transient production of TGF-beta 2 by postnatal cerebellar neurons and its effect on neuroblast proliferation | Q48129225 | ||
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification | Q48194323 | ||
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect | Q48249566 | ||
Transforming growth factor-beta 2 both stimulates and inhibits neurogenesis of rat cerebellar granule cells in culture | Q48888000 | ||
TGF-beta2 neutralization inhibits proliferation and activates apoptosis of cerebellar granule cell precurors in the developing cerebellum | Q48945809 | ||
The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. | Q53492300 | ||
Adult medulloblastoma comprises three major molecular variants. | Q55463035 | ||
P433 | issue | 2 | |
P921 | main subject | medulloblastoma | Q1333608 |
P304 | page(s) | 178-191 | |
P577 | publication date | 2012-10-11 | |
P1433 | published in | Brain Pathology | Q4955776 |
P1476 | title | Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development | |
P478 | volume | 23 |
Q47116612 | 4SC-202 as a Potential Treatment for the Pediatric Brain Tumor Medulloblastoma |
Q35904348 | ASC deficiency suppresses proliferation and prevents medulloblastoma incidence |
Q37196585 | Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma |
Q90235802 | Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization |
Q91711195 | Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions |
Q34131951 | Role of the miR-17∼92 cluster family in cerebellar and medulloblastoma development |
Q39008734 | SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors |
Q92924437 | Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments |
Q38616153 | Sonic hedgehog patterning during cerebellar development |
Q26777997 | Targeting the Hedgehog Pathway in Pediatric Medulloblastoma |
Q92563867 | The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma |
Q38469127 | Transforming growth factor β and bone morphogenetic protein actions in brain tumors |
Q30581795 | Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer |